NEW YORK – Investment bank JP Morgan has assigned an Overweight rating to the stocks of both Thermo Fisher Scientific and Qiagen a week after Thermo Fisher's planned acquisition of Qiagen fell through due to resistance from a substantial portion of Qiagen shareholders.
JP Morgan moved to an Overweight rating on both companies from a Not Rated designation assigned during a restriction period as the potential acquisition played out.